Strong demand for lenacapavir HIV-prevention injection raises supply concerns in South Africa

Author: iol.co.zaPublished on: November 22, 2026Country: South Africa
Health
Strong demand for lenacapavir HIV-prevention injection raises supply concerns in South Africa

Since its official launch on June 5, lenacapavir, a twice-yearly HIV-prevention injection, has drawn strong interest in South Africa, particularly among young people, women and key populations. The rollout is under way in six provinces and 24 districts, with the Free State, Limpopo and Northern Cape expected to join in later phases. Deputy Health Minister Dr Joe Phaahla said uptake was strong but warned that supplies and production capacity might not meet demand.

Stay informed with NewsBoulevard

Get the latest news summaries delivered to your inbox

Related News

Morocco: The new mission undertaken by former Senegalese president Macky Sall
HealthWorld / InternationalMorocco
senenews.com•

Morocco: The new mission undertaken by former Senegalese president Macky Sall

At the Dakhla Global Summit in Morocco, Macky Sall delivered the opening address on November 20, 2026, and set out five priorities for strengthening African health systems. He called for stronger health infrastructure, better training and retention of healthcare workers, and expanded local vaccine production, with a continental target of producing 60% of required vaccines locally by 2040. He cited the MADIBA project in Diamniadio, Senegal, and Morocco’s MARBIO unit as examples of Dakar-Rabat industrial cooperation. His other priorities include sustainable funding, digital technologies and artificial intelligence, and pan-African cooperation on research, pooled medical procurement, and health diplomacy.

Read More

Stay Updated with NewsBoulevard

Subscribe to our newsletter for the latest news summaries delivered to your inbox